[Form 4] Fulgent Genetics, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Paul Kim, identified as CFO and Treasurer of Fulgent Genetics, Inc. (FLGT), reported a transaction dated 09/01/2025 in which 1,131 shares of the issuer's common stock were disposed of under transaction code F at a price of $22.17 per share. The filing explains these shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units originally granted on February 28, 2022. After the withholding, the reporting person beneficially owns 336,861 shares, held directly. The Form 4 is signed by Paul Kim on 09/03/2025.

Positive

• Disclosure completeness: Form 4 includes transaction code, amount, price, reason for disposition, and post-transaction holdings.
• Substantial remaining ownership: Reporting person retains 336,861 shares after the withholding, indicating continued material alignment with shareholders.

Negative

• Share reduction: 1,131 shares were disposed (withheld) to satisfy tax obligations, reducing the reporting person's direct holdings.
• Price sensitivity: Withholding occurred at an effective price of $22.17, which may reflect the vesting valuation but slightly reduces the insider's share count.

Insights

Financial Analyst

TL;DR: Routine tax-withholding on vested RSUs reduced the CFO's share count by 1,131 shares; remaining stake remains sizable.

The reported transaction is coded F, indicating shares were withheld to cover tax obligations on vested restricted stock units, not an open-market sale. Withholding at $22.17 per share reduced the reporting person's direct holdings to 336,861 shares, which remains a material ownership position. This type of transaction is typically administrative and does not necessarily signal a change in conviction by the insider. Investors should note the origin of the shares (RSU vesting on 02/28/2022) as disclosed in the explanation.

Corporate Governance Expert

TL;DR: Disclosure aligns with Section 16 requirements; withholding for taxes on vested awards is standard practice.

The Form 4 provides the required detail: reporting person, relationship to issuer (CFO and Treasurer), transaction date, code F, number of shares withheld, price per share, and post-transaction beneficial ownership. The explanation links the withholding to a previously reported RSU grant. From a governance and compliance perspective, the filing appears complete and timely, with manual signature dated 09/03/2025. No governance red flags are evident in the disclosed facts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Paul

(Last) (First) (Middle)

C/O FULGENT GENETICS, INC.

4399 SANTA ANITA AVENUE

(Street)

EL MONTE CA 91731

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO and Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2025		F		1,131(1)	D	$22.17	336,861	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.

	/s/ Paul Kim	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did FLGT CFO Paul Kim report on Form 4?

The filing reports 1,131 shares disposed under code F (withheld to satisfy taxes) on 09/01/2025 at $22.17 per share.

Why were the 1,131 FLGT shares disposed?

The shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on 02/28/2022.

How many FLGT shares does Paul Kim own after the transaction?

After the withholding, Paul Kim beneficially owns 336,861 shares, held directly.

Was this an open-market sale reported on the Form 4?

No. The transaction is coded F, indicating shares were withheld for tax purposes rather than sold in the open market.

When was the Form 4 signed by the reporting person?

The Form 4 bears the reporting person's signature dated 09/03/2025.